首页> 外国专利> METHOD FOR CORRECTION OF INNATE AND ADAPTIVE IMMUNITY FACTORS DYSFUNCTION FOR CHRONIC RENAL FAILURE IN EXPERIMENT

METHOD FOR CORRECTION OF INNATE AND ADAPTIVE IMMUNITY FACTORS DYSFUNCTION FOR CHRONIC RENAL FAILURE IN EXPERIMENT

机译:实验中慢性肾功能衰竭的固有和适应性免疫功能障碍的纠正方法

摘要

FIELD: medicine.;SUBSTANCE: starting from the 21st day of chronic renal failure simulation, calcium channel blocking amlodipine drug is administered to rats using a pipette at a dose of 0.25 mg/kg per day per animal, for 7 days. Changes in innate and adaptive immunity factors in relation to the performance of laboratory animals who do not receive amlodipine, are recorded. At that, innate immunity cell factors state normalization, phagocytosis and reactive oxygen forms generation ability, intensity of delayed hypersensitivity reaction, increasing of theantibody-forming cells number in the spleen, are established.;EFFECT: method application expands information on the chronic renal failure pathogenesis mechanisms, does not require scarce supplies, is available in the research centers practice, is important for calcium channel blockers efficiency analysis for chronic renal failure treatment.;2 tbl
机译:领域:药物;研究对象:从模拟慢性肾衰竭的第21天开始,使用移液器以每只动物每天0.25 mg / kg的剂量向大鼠施用钙通道阻断氨氯地平药物,持续7天。记录与不接受氨氯地平的实验动物的性能有关的先天性和适应性免疫因子的变化。那时,先天免疫细胞因子表明了正常化,吞噬作用和活性氧形式的产生能力,迟发型超敏反应的强度,脾脏中抗体形成细胞数量的增加。;效果:方法的应用扩展了关于慢性肾衰竭的信息发病机理,不需要稀缺物资,可在研究中心实践中找到,对于慢性肾脏衰竭治疗中钙通道阻滞剂的效率分析很重要。2

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号